Search for: "FANNING v. SEATTLE SCHOOL DISTRICT NO. 1"
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
25 Apr 2007, 2:15 am
SEATTLE SCHOOL DISTRICT NO. 1 ??? [read post]
11 Oct 2011, 12:27 pm
Seattle School District No. 1 – that they view the use of race as the basis for any government decisions as deeply suspect under the Fourteenth Amendment. [read post]
1 Jan 2012, 8:19 am
The defendants initially removed the lawsuit to the United States District Court for the Eastern District of Wisconsin, but on December 9, 1965, District Court Judge Robert Tehan remanded the case to the state circuit court where trial was conducted by Circuit Court Judge and former Marquette Law School professor, Elmer W. [read post]
5 May 2010, 12:21 pm
Seattle School District No. 1, in which the conservative majority proscribed Seattle’s voluntarily adopted desegregation plan: The Court has changed significantly since … 1968. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
